WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerationsReview article Published on 2022-03-012022-10-05 Journal: Vaccine [Category] COVID19(2023년), SARS, 임상, [키워드] Coverage COVID-19 vaccine COVID-19 vaccine trial expert group Guidance implication National next generation vaccines placebo controlled trial placebo-controlled trial Placebo-controlled trials question raise Research Ethics Standard of care Standard of prevention Trial Trial designs vaccination Vaccines while WHO [DOI] 10.1016/j.vaccine.2022.02.038 [Article Type] Review article
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis2020년 3월부터 2021년 8월까지 인도에서 SARS-CoV-2에 대한 IgG 항체의 혈청 유병률: 체계적인 검토 및 메타 분석Review Published on 2022-03-012022-09-12 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, [키워드] 95% CI Abstract age calculated caused Combination confidence Course COVID-19 COVID-19 pandemic critical appraisal cross-sectional study demographic characteristics demographics duplicates excluded explained First wave good quality Government had more highest highlight IgG antibody India information interval Joanna Briggs Institute Laboratory Meta-analysis not differ pandemic participant patients with COVID-19 protocols Replication reported Reporting risk of bia Sample size SARS-CoV-2 searched second wave selected Seroprevalence systematic review vaccinated individuals WHO women [DOI] 10.1016/j.ijid.2021.12.353 PMC 바로가기 [Article Type] Review
Neutralizing antibody: a savior in the Covid-19 disease중화항체: 코로나19의 구세주Review Published on 2022-03-012022-09-11 Journal: Molecular biology reports [Category] MERS, SARS, 변종, 유전자 메커니즘, 임상, 진단, [키워드] ACE2 angiotensin Angiotensin converting enzyme-2 (ACE2) receptor antibody binding clinical trial combating Community community health components Convalescent plasma transfer (CPT) coronavirus COVID-19 COVID-19 disease COVID-19 infection Defense defense mechanism diagnostic disease enzyme Health Health Organization human lung cells humoral immune immune surveillance immune system immunogenic Infection Infectious disease Infectious diseases interact life mechanism monoclonal antibodies monoclonal antibody MOST Neutralizing antibodies neutralizing antibody outbreak pandemic plasma Plasma cell Plasma cells plasma therapy Protein RBD receptor Receptor-binding domain Receptor-binding domain (RBD) recognize reduce secreted shown Spike protein Surveillance the receptor-binding domain the spike protein therapeutic therapy transfer Vaccine development Viral Viral load virus WHO World Health Organization [DOI] 10.1007/s11033-021-07020-6 PMC 바로가기 [Article Type] Review
Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review모유 내 SARS-CoV-2 특이 항체의 역가 및 중화 능력: 체계적인 검토Article Published on 2022-03-012022-09-12 Journal: Archives of disease in childhood. Fetal and neonat [Category] MERS, SARS, 진단, [키워드] anti-SARS-CoV-2 antibody articles Asymptomatic asymptomatic infection CINAHL CNKI COVID-19 COVID-19 infection current database demonstrated disease Evidence Google Scholar Holder Human human milk IgA IgG IgM illness immunoglobulin A in vitro individual individuals with COVID-19 Infection lactating Mild milk neonatology neutralise neutralising Neutralising Antibodies neutralising antibody outcome performed Presence preserved provided SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 virus SARS-CoV-2-specific antibody selected severe disease severity Study design systematic review tested Virology WHO with COVID-19 [DOI] 10.1136/archdischild-2021-322156 PMC 바로가기 [Article Type] Article
Introduction of SARS-CoV-2 C.37 (WHO VOI lambda) in the Sao Paulo State, Southeast Brazil브라질 남동부 상파울루 주에 SARS-CoV-2 C.37(WHO VOI 람다) 도입Case Reports Published on 2022-03-012022-09-11 Journal: Journal of medical virology [Category] SARS, 변종, [키워드] Brazil Case report characterized circulating variants circulation Contact COVID-19 COVID-19 symptom COVID-19 symptoms dissemination effective Hospitalization individual Infection isolate Lambda Lambda variant Latin mild symptoms molecular Molecular epidemiology network positive positive patients reported SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 variant SARS-CoV-2 variants sequenced genome Seven state Surveillance the SARS-CoV-2 Transmission variants variants of interest WHO [DOI] 10.1002/jmv.27389 PMC 바로가기 [Article Type] Case Reports
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies다발성 경화증에서 COVID-19로 인한 사망 위험 증가: 관찰 연구의 통합 분석Meta-Analysis Published on 2022-03-012022-09-11 Journal: Journal of Neurology [Category] SARS, 치료기술, [키워드] age Analysis analyzed articles calculated caution CDR Cohort studies cohort study cohorts conducted confidence interval confirmation COVID-19 COVID-19 case COVID-19 in patient criteria Crude death rate death rate died General population Health Organization heterogeneity Increased males Multiple multiple sclerosis observational study pandemic Patient provided risk of death SARS-CoV-2 sensitivity analysis surveillance data website WHO World Health Organization yielding [DOI] 10.1007/s00415-021-10803-3 PMC 바로가기 [Article Type] Meta-Analysis
WHO prequalified tocilizumab and vaccine boosters against COVID-19WHO, COVID-19에 대한 토실리주맙 및 백신 부스터 사전 인증Article Published on 2022-03-012022-09-12 Journal: International journal of surgery (London, England) [Category] MERS, 진단, [키워드] Abstract booster COVID-19 omicron pandemic SARS-CoV-2 Tocilizumab Vaccine WHO WHO. [DOI] 10.1016/j.ijsu.2022.106593 PMC 바로가기 [Article Type] Article
Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids A Bayesian Reanalysis of a Previous Meta-analysis토실리주맙 및 코르티코스테로이드로 치료받은 COVID-19 감염 입원 환자의 사망률 이전 메타 분석의 베이지안 재분석Meta-Analysis Published on 2022-02-282022-09-12 Journal: JAMA Network Open [Category] MERS, 진단, [키워드] age all-cause mortality Analysis association Bayesian Bayesian methods benefit Can Care clinically concerning Corticosteroid Corticosteroids country COVID-19 credible interval CrI distributions evaluate evaluated finding Future greater Health Organization Hierarchical hospitalized patient hospitalized patients Importance IMV interval Invasive mechanical ventilation magnitude measure men Meta-analysis Mortality mortality risk NIV Noninvasive ventilation objective Odds ratio oxygen oxygen only participant Patient patients with COVID-19 Placebo Point posterior probability Probability randomization Randomized randomized clinical trial Rate receiving reduced Relevance Research Respiratory Support Result risk risk difference robustness setting subgroup subgroups survival the WHO Tocilizumab treated treatment with tocilizumab Trial usual care was performed WHO with COVID-19 World Health Organization [DOI] 10.1001/jamanetworkopen.2022.0548 PMC 바로가기 [Article Type] Meta-Analysis
The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian ExperienceC형 간염 퇴치를 위한 교도소의 중요성: 호주 경험에서 얻은 통찰력Article Published on 2022-02-282022-09-11 Journal: Viruses [Category] 치료제, [키워드] acceptability approaches changed Community country Coverage COVID-19 pandemic criminal Critical declined demonstrated direct-acting antiviral disease disease elimination drug drugs effective Efficacy Evidence evidence of example experience Health Organization Health Service Hepatitis hepatitis C hepatitis C virus implementation Importance Imprisonment IMPROVE increase in Infection insight involved People who inject drugs populations Prevalence prison prisons provide public health threat reduction required treat treated Treatment WHO World Health Organization [DOI] 10.3390/v14030497 PMC 바로가기 [Article Type] Article
HCV Elimination in Central Europe with Particular Emphasis on Microelimination in PrisonsReview Published on 2022-02-262023-06-18 Journal: Viruses [Category] MERS, [키워드] Epidemiology HCV Hepatitis Screening therapy WHO [DOI] 10.3390/v14030482 PMC 바로가기 [Article Type] Review